Kairos Pharma (KAPA) vs Moolec Science SA (MLEC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Kairos Pharma is the larger company by market cap ($2.7 million vs $1.6 million), about 1.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KAPA | MLEC |
|---|---|---|
| Share price | $0.8103 | $2.20 |
| Market cap | $2.74M | $1.60M |
| 1-day change | -15.55% | -47.49% |
| EPS (TTM) | $-1.96 | $-199.02 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.24 | $23.22 |
| 52-week low | $0.7827 | $1.99 |
| Distance from 52-week high | -91.23% | -90.53% |
| Analyst consensus | none | — |
| Avg. price target upside | +5947.14% | — |
| Average volume | 602.89K | 17.09K |
| Shares outstanding | 3.39M | 726.12K |
| Employees | 1 | — |
| Sector | Health Care | Finance |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Kairos Pharma in Health Care and Moolec Science SA in Finance.
About Kairos Pharma
KAPA stock →Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company, develops immunotherapy and cell therapies for the treatment of cancer. The company offers therapeutics, including antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.
Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees
About Moolec Science SA
MLEC stock →Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas.
Finance · Blank Checks
KAPA vs MLEC FAQ
Which is bigger, Kairos Pharma or Moolec Science SA?
Kairos Pharma (KAPA) is larger, with a market capitalization of $2.74M compared with $1.60M for Moolec Science SA (MLEC).
Are Kairos Pharma and Moolec Science SA in the same industry?
No. Kairos Pharma is in the Health Care sector, while Moolec Science SA is in Finance.